Sunday, February 26, 2017 1:06:07 PM
$30MM per 1% of the market in an earlier post. 20% of the market
would equate roughly to $600MM revenue. Cut that in half to remove taxes and expenses and you have a net earn of $300MM. Divided by
141MM shares and you have an EPS of 2.12. Biotechs have P/E's in the
hundreds, so a low one would be 100= $212 share price. 50% market share would be a crazy number.
What's that about not being able to support an $8B market cap?
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM